Endocrine tumors of the gastrointestinal tract: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +)) |
No edit summary |
||
Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
Line 12: | Line 11: | ||
# [[Vipoma]]s | # [[Vipoma]]s | ||
# [[Somatostatinoma]]s | # [[Somatostatinoma]]s | ||
# | # [[GRFoma]]s | ||
# PPomas / Nonfunctioning pancreatic endocrine tumors (PETs) | # PPomas / Nonfunctioning [[pancreatic endocrine tumors]] (PETs) | ||
# Other PETs | # Other PETs | ||
Revision as of 16:09, 17 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Endocrine tumors of the gastrointestinal tract may include:
- Multiple endocrine neoplasia
- Insulinomas
- Gastrinomas
- Glucagonomas
- Vipomas
- Somatostatinomas
- GRFomas
- PPomas / Nonfunctioning pancreatic endocrine tumors (PETs)
- Other PETs